Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities

Completed

Conditions studied: Infantile Hemangiomas

In brief

A combined set of quantitative skin imaging methods will quantitatively describe the natural ontogeny and the response to standard treatments over time in patients with infantile hemangiomas.

Key facts

Study ID

NCT02061735

Run by

Children's Hospital Medical Center, Cincinnati

People needed

118

Starts

2011-10-01

Expected to finish

2015-04-01

Last updated by the study team

2015-05-06

Who can join

Age: 0 and older, up to 5. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≤ 5 years of age
• Diagnosis of a cutaneous infantile hemangioma
• Diagnosis of hemangioma requiring treatment (treatment includes: propranolol or topical timolol) or diagnosis of an infantile hemangioma that will not be treated at the time of enrollment
• Able to tolerate imaging procedures

You may not qualify if…

• Age > 5 years
• Non cutaneous infantile hemangioma
• Hemangioma on the lip
• Hemangioma on the eyelid
• Hemangioma located in areas whereby measurements cannot be made due to equipment limitations
• Deep hemangioma with no visible skin surface component
• Congenital hemangioma
• No available normal site for study control
• Other vascular anomaly
• Not able to tolerate imaging procedures

Where it is running

• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.